SOLVONIS THERAPEUTICS PLC (SVNS.L)
SOLVONIS THERAPEUTICS PLC reported revenue of 0 GBP for the year ending 31 December 2025.
Every figure below is the company's own, as filed. Nothing is estimated and
nothing is smoothed — a period the filing does not support is left blank rather than
filled in.
Quarters are the company's own, counted from its financial
year ending 12-31.
Amounts in GBP.
The same series drawn ›
As last reported
The newest period the filing supports for each figure, in GBP.
| Figure | Period | Amount | Year on year |
|---|
| Revenue |
2025 · ending 31 December 2025 |
0 |
— |
| Gross Profit |
2024 · ending 31 December 2024 |
0 |
-100.0% |
| Operating Income |
2025 · ending 31 December 2025 |
-5.7M |
— |
| Net Income |
2025 · ending 31 December 2025 |
-5.7M |
— |
| Operating Cash Flow |
2025 · ending 31 December 2025 |
-3.3M |
— |
| Free Cash Flow |
2024 · ending 31 December 2024 |
-1.1M |
— |
Revenue and profit by financial year
As filed, in GBP. A year the filing does not support is not listed.
| Year | Ending |
Revenue | Operating Income | Net Income | Free Cash Flow |
|---|
| 2025 | 2025-12-31 |
0 | -5.7M | -5.7M | — |
|---|
| 2024 | 2024-12-31 |
0 | -1.4M | -1.6M | -1.1M |
|---|
| 2023 | 2023-12-31 |
587K | -3.1M | -3.1M | -1.5M |
|---|
| 2022 | 2022-12-31 |
542K | -2.7M | -2.7M | -3.1M |
|---|
Every period
Revenue Annual
| Period | Ending | Revenue |
|---|
| FY25 | 2025-12-31 | 0 |
|---|
| FY24 | 2024-12-31 | 0 |
|---|
| FY23 | 2023-12-31 | 587K |
|---|
| FY22 | 2022-12-31 | 542K |
|---|
Gross Profit Annual
| Period | Ending | Gross Profit |
|---|
| FY24 | 2024-12-31 | 0 |
|---|
| FY23 | 2023-12-31 | 258K |
|---|
| FY22 | 2022-12-31 | 300K |
|---|
Operating Income Annual
| Period | Ending | Operating Income |
|---|
| FY25 | 2025-12-31 | -5.7M |
|---|
| FY24 | 2024-12-31 | -1.4M |
|---|
| FY23 | 2023-12-31 | -3.1M |
|---|
| FY22 | 2022-12-31 | -2.7M |
|---|
Net Income Annual
| Period | Ending | Net Income |
|---|
| FY25 | 2025-12-31 | -5.7M |
|---|
| FY24 | 2024-12-31 | -1.6M |
|---|
| FY23 | 2023-12-31 | -3.1M |
|---|
| FY22 | 2022-12-31 | -2.7M |
|---|
Operating Cash Flow Annual
| Period | Ending | Operating Cash Flow |
|---|
| FY25 | 2025-12-31 | -3.3M |
|---|
| FY24 | 2024-12-31 | -1.1M |
|---|
| FY23 | 2023-12-31 | -1.2M |
|---|
| FY22 | 2022-12-31 | -2.4M |
|---|
Free Cash Flow Annual
Operating cash flow minus capital expenditure.
| Period | Ending | Free Cash Flow |
|---|
| FY24 | 2024-12-31 | -1.1M |
|---|
| FY23 | 2023-12-31 | -1.5M |
|---|
| FY22 | 2022-12-31 | -3.1M |
|---|